HALO beats Q1 earnings estimates as royalty revenues from partner drugs and strong product sales lift revenues by 42% year over year.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
315last 24h
2132last 7d
379● bullish (7d)
186● bearish (7d)
204publishers
Zacks92d agobullish
Halozyme's Q1 Earnings & Revenues Beat Estimates, Stock UpMarketBeat98d agoneutral
J & J Snack Foods Q2 Earnings Call HighlightsJ & J Snack Foods (NASDAQ:JJSF) reported fiscal second-quarter 2026 results that showed margin expansion and higher adjusted earnings despite a decline in sales, as management pointed to benefits from its “Project Apollo” transformation and ongoing portfolio reshaping. Chief Executive Officer D